[1]
“The Era of IL-23: Introduction of Tildrakizumab”, Can Dermatol Today, vol. 2, no. s03, p. 2, Mar. 2021, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/2-s03-gooderham